Created collaboratively by committee members, the Principles Statement is comprised of four key principles and associated actions that are vital to the work of ensuring all trials are diverse, inclusive, and equitable.
ACRO Chair and Executive Industry Advisor at Medidata, Jackie Kent, BS, authored an Op-Ed for MedPage Today on how broader representation can help address health disparities and improve patient outcomes.
Our member companies have faced widespread clinical trial disruptions
in the past few years - from the global pandemic, to the war in Ukraine.
We developed a recommendation for how sponsors and CROs should
report study disruptions in a Clinical Study Report (CSR).
Read about ACRO’s initiatives, COVID-19 efforts, and more.
Take a look at how our members are innovating in top focus areas.
#ClinicalTrial teams can develop innovative and efficient protocol designs through remote monitoring activities, but that requires optimization, says @PPDCRO Get tips on implementation and best practices for your decentralized studies: https://bit.ly/3CgmoyI
Unconscious bias training can improve self-awareness of personal biases to help create more inclusive workplaces, and @Labcorp provided this training to over 6,200 global managers. Read more in its corporate responsibility report: https://bit.ly/3r878gV
One key piece of developing connection and belonging for employees at any #LifeSciences organization? Dedicated people leaders. See how @ICONplc created a shared commitment, trained its leadership, and raised awareness to improve inclusion. https://bit.ly/3BOAC8n
Get ACRO’s newsletter to stay informed about our work and the industry.
Our member companies have faced widespread clinical trial disruptions in the past few years – from the global pandemic, to the war…
WASHINGTON, DC – This week, the Association of Clinical Research Organizations (ACRO)’s Diversity and Inclusion in Clinical Trials committee is proud to…
The below is an Op-Ed authored by ACRO Chair, Jackie Kent, for MedPage Today on August 6, 2022. Read the full article…
Washington, DC — On March 16, 2022, ACRO’s Board of Directors was joined by more than 125 clinical research stakeholders – including…
Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Jackie…
The below is the Op-Ed authored by ACRO Executive Director, Doug Peddicord for Morning Consult on November 3, 2021. Read the full…
Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »
ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »
ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »
In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »
ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »
We help create a global regulatory and business environment
where ACRO members succeed
';